345 related articles for article (PubMed ID: 33112036)
1. SARS-CoV-2 evades immune detection in alveolar macrophages.
Dalskov L; Møhlenberg M; Thyrsted J; Blay-Cadanet J; Poulsen ET; Folkersen BH; Skaarup SH; Olagnier D; Reinert L; Enghild JJ; Hoffmann HJ; Holm CK; Hartmann R
EMBO Rep; 2020 Dec; 21(12):e51252. PubMed ID: 33112036
[TBL] [Abstract][Full Text] [Related]
2. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
Vanderheiden A; Ralfs P; Chirkova T; Upadhyay AA; Zimmerman MG; Bedoya S; Aoued H; Tharp GM; Pellegrini KL; Manfredi C; Sorscher E; Mainou B; Lobby JL; Kohlmeier JE; Lowen AC; Shi PY; Menachery VD; Anderson LJ; Grakoui A; Bosinger SE; Suthar MS
J Virol; 2020 Sep; 94(19):. PubMed ID: 32699094
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 Isolates Show Impaired Replication in Human Immune Cells but Differential Ability to Replicate and Induce Innate Immunity in Lung Epithelial Cells.
Jiang M; Kolehmainen P; Kakkola L; Maljanen S; Melén K; Smura T; Julkunen I; Österlund P
Microbiol Spectr; 2021 Sep; 9(1):e0077421. PubMed ID: 34378952
[TBL] [Abstract][Full Text] [Related]
4. Interferon-Lambda Intranasal Protection and Differential Sex Pathology in a Murine Model of SARS-CoV-2 Infection.
Sohn SY; Hearing J; Mugavero J; Kirillov V; Gorbunova E; Helminiak L; Mishra S; Mackow E; Hearing P; Reich NC; Kim HK
mBio; 2021 Dec; 12(6):e0275621. PubMed ID: 34724828
[TBL] [Abstract][Full Text] [Related]
5. Type I and III interferon responses in SARS-CoV-2 infection.
Kim YM; Shin EC
Exp Mol Med; 2021 May; 53(5):750-760. PubMed ID: 33953323
[TBL] [Abstract][Full Text] [Related]
6. Alveolar Macrophages Can Control Respiratory Syncytial Virus Infection in the Absence of Type I Interferons.
Makris S; Bajorek M; Culley FJ; Goritzka M; Johansson C
J Innate Immun; 2016; 8(5):452-63. PubMed ID: 27423203
[TBL] [Abstract][Full Text] [Related]
7. Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2.
Hatton CF; Botting RA; Dueñas ME; Haq IJ; Verdon B; Thompson BJ; Spegarova JS; Gothe F; Stephenson E; Gardner AI; Murphy S; Scott J; Garnett JP; Carrie S; Powell J; Khan CMA; Huang L; Hussain R; Coxhead J; Davey T; Simpson AJ; Haniffa M; Hambleton S; Brodlie M; Ward C; Trost M; Reynolds G; Duncan CJA
Nat Commun; 2021 Dec; 12(1):7092. PubMed ID: 34876592
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.
Chen H; Liu W; Wang Y; Liu D; Zhao L; Yu J
EBioMedicine; 2021 Aug; 70():103500. PubMed ID: 34311326
[TBL] [Abstract][Full Text] [Related]
9. Increased Sensitivity of SARS-CoV-2 to Type III Interferon in Human Intestinal Epithelial Cells.
Metz-Zumaran C; Kee C; Doldan P; Guo C; Stanifer ML; Boulant S
J Virol; 2022 Apr; 96(7):e0170521. PubMed ID: 35262371
[TBL] [Abstract][Full Text] [Related]
10. An Update on Innate Immune Responses during SARS-CoV-2 Infection.
Zhang Y; Chen S; Jin Y; Ji W; Zhang W; Duan G
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696490
[TBL] [Abstract][Full Text] [Related]
11. Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison.
Galani IE; Rovina N; Lampropoulou V; Triantafyllia V; Manioudaki M; Pavlos E; Koukaki E; Fragkou PC; Panou V; Rapti V; Koltsida O; Mentis A; Koulouris N; Tsiodras S; Koutsoukou A; Andreakos E
Nat Immunol; 2021 Jan; 22(1):32-40. PubMed ID: 33277638
[TBL] [Abstract][Full Text] [Related]
12. Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia.
Grant RA; Morales-Nebreda L; Markov NS; Swaminathan S; Querrey M; Guzman ER; Abbott DA; Donnelly HK; Donayre A; Goldberg IA; Klug ZM; Borkowski N; Lu Z; Kihshen H; Politanska Y; Sichizya L; Kang M; Shilatifard A; Qi C; Lomasney JW; Argento AC; Kruser JM; Malsin ES; Pickens CO; Smith SB; Walter JM; Pawlowski AE; Schneider D; Nannapaneni P; Abdala-Valencia H; Bharat A; Gottardi CJ; Budinger GRS; Misharin AV; Singer BD; Wunderink RG;
Nature; 2021 Feb; 590(7847):635-641. PubMed ID: 33429418
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 Evasion of the Interferon System: Can We Restore Its Effectiveness?
Sacchi A; Giannessi F; Sabatini A; Percario ZA; Affabris E
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298304
[TBL] [Abstract][Full Text] [Related]
14. Alveolar macrophages: Achilles' heel of SARS-CoV-2 infection.
Wang Z; Li S; Huang B
Signal Transduct Target Ther; 2022 Jul; 7(1):242. PubMed ID: 35853858
[TBL] [Abstract][Full Text] [Related]
15. Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection.
Severa M; Diotti RA; Etna MP; Rizzo F; Fiore S; Ricci D; Iannetta M; Sinigaglia A; Lodi A; Mancini N; Criscuolo E; Clementi M; Andreoni M; Balducci S; Barzon L; Stefanelli P; Clementi N; Coccia EM
PLoS Pathog; 2021 Sep; 17(9):e1009878. PubMed ID: 34473805
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801.
Wahl A; Gralinski LE; Johnson CE; Yao W; Kovarova M; Dinnon KH; Liu H; Madden VJ; Krzystek HM; De C; White KK; Gully K; Schäfer A; Zaman T; Leist SR; Grant PO; Bluemling GR; Kolykhalov AA; Natchus MG; Askin FB; Painter G; Browne EP; Jones CD; Pickles RJ; Baric RS; Garcia JV
Nature; 2021 Mar; 591(7850):451-457. PubMed ID: 33561864
[TBL] [Abstract][Full Text] [Related]
17. Type I interferon signaling induces a delayed antiproliferative response in respiratory epithelial cells during SARS-CoV-2 infection.
Bragazzi Cunha J; Leix K; Sherman EJ; Mirabelli C; Frum T; Zhang CJ; Kennedy AA; Lauring AS; Tai AW; Sexton JZ; Spence JR; Wobus CE; Emmer BT
J Virol; 2023 Dec; 97(12):e0127623. PubMed ID: 37975674
[TBL] [Abstract][Full Text] [Related]
18. Characterization of SARS-CoV-2 Evasion: Interferon Pathway and Therapeutic Options.
Znaidia M; Demeret C; van der Werf S; Komarova AV
Viruses; 2022 Jun; 14(6):. PubMed ID: 35746718
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 sensing by RIG-I and MDA5 links epithelial infection to macrophage inflammation.
Thorne LG; Reuschl AK; Zuliani-Alvarez L; Whelan MVX; Turner J; Noursadeghi M; Jolly C; Towers GJ
EMBO J; 2021 Aug; 40(15):e107826. PubMed ID: 34101213
[TBL] [Abstract][Full Text] [Related]
20. Alveolar macrophages contribute to the pathogenesis of human metapneumovirus infection while protecting against respiratory syncytial virus infection.
Kolli D; Gupta MR; Sbrana E; Velayutham TS; Chao H; Casola A; Garofalo RP
Am J Respir Cell Mol Biol; 2014 Oct; 51(4):502-15. PubMed ID: 24749674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
